“Advanced Wound Care market set to grow to $12bn by 2022” says new Visiongain report

30 August 2018
Pharma

Visiongain has launched a new pharma report Advanced Wound Care Market Forecast 2018-2028: Revenue Prospects by Products for Active Wound Care Dressings (Antimicrobial, Foam, Hydrocolloid, Film, Alginate, Hydrogel, Other), Wound Care Devices (NPWT, Ultrasound, Other) and Wound Care Biologics (Skin Replacement, Collagen-Based, Cell-Based, Other), Applications, End-Users and National Market.

Being the largest and fastest growing segment of the wound care market, the advanced wound care market will witness healthy growth during the forecast period. The increasing prevalence of chronic wounds such as venous ulcers, diabetic ulcers and pressure sores is creating demand for more innovative products. It is estimated that around 89 million wounds occur every year; of these around 30 million are chronic wounds and 15 million are burns. Chronic wound incidences will be boosted by the increase in the global over-65 population and rising diabetes incidence both in emerging and mature economies.

The lead analyst of the report commented "The advanced wound care market is expected to experience considerable growth over the forecast period. The main drivers for the growth include an increasingly ageing population, rising prevalence of diabetes and obesity, and growing patient awareness of available products.

In the case of patients suffering from chronic wounds, wound care has become a necessity in order to reduce the risk of morbidity. The number of patients suffering from all forms of chronic wounds is increasing worldwide at around 8% per year; this increasing incidence provides an avenue for substantial growth in the advanced wound care market over the coming years."

Leading companies featured in the report include Acelity, Coloplast, ConvaTec, Mölnlycke, Organogenesis, Smith & Nephew. Notes for Editors If you are interested in a more detailed overview of this report, please send an e-mail to sara.peerun@visiongain.com or call her on +44 (0) 207 336 6100 About Visiongain Visiongain is one of the fastest-growing and most innovative independent media companies in Europe. Based in London, UK, Visiongain produces a host of business-to-business reports cusing on the automotive, aviation, chemicals, cyber, defence, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors.

Visiongain publishes reports produced by analysts who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.

Recent News

Visiongain Publishes OTC Drugs & Dietary Supplements Market Report 2020-2030

The increasing rates of patent expiry lead to a counter-strategy of switching companies from Rx to OTC. In the US, according to the Consumer Healthcare Products Association, approximately 106 ingredients and dosage strengths have undergone a change from Rx to OTC to around 700 OTC products on the market.

23 September 2020

Read

Visiongain Publishes Healthcare Cold Chain Logistics Market Report 2020-2030

. The growth of this market is majorly driven by increasing sales of temperature sensitive pharmaceutical products, longer life expectancy and rising geriatric population are some of the prominent factors.

16 September 2020

Read

Visiongain Publishes Vaccines Sales Market Report 2020-2030

Visiongain forecasts a continuing growth in global market, submarket and product sales as human vaccines drive pharmaceutical business sales. New key players and technological progress will enter the industry, leading to an increase in the market size of the world market for human vaccines in general.

14 September 2020

Read

Visiongain Publishes Ophthalmic Ultrasound Systems Market Report 2020-2030

The global ophthalmic ultrasound systems market is driven by factors such as the increasing prevalence of ocular disorders and diseases, adoption of novel ophthalmic technologies, rising focus on research & development, and growing health awareness amongst the population.

09 September 2020

Read

Kelloggs
3m
Thales
Shell
TEVA
Lockheed-Martin
Pfizer
Raytheon
Halliburton
Du-Pont
Honeywell
Daimler
BASF
Bayer
BP
BAE-Systems
Unilever